US appeals court rules in late-night decision abortion drug mifepristone to remain available for now
JURIST
APRIL 13, 2023
This comes amid conflicting rulings, with anti-abortion rights groups challenging the FDA’s approval of mifepristone and 17 states, along with the District of Columbia, fighting to preserve access to the medication. These conflicting rulings may require the US Supreme Court’s intervention to resolve the conflict.
Let's personalize your content